Barely Significant
← all excerpts

Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia.

Int J Mol Sci · 2015 · PMC4730274 · PMID 26712750

Europe PMCDOI
1
hedged sentence
0.0690
closest p · 1.4× alpha
0.0690
boldest claim

The sentences

showed a trendp = 0.069so close (0.05 < p ≤ 0.1)
The group of CRF rats treated with rHuEPO, as compared to CRF rats without treatment, showed a trend ( p = 0.069) towards a reduction in mild tubulointerstitial lesions ( Table 3 and Figure 5 B3), but a significant increase in advanced lesions, namely in hyaline cylinders, calcification, necrosis and IFTA ( Table 3 and Figure 5 B6).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.